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Abstract
Background: Estimating a realistic effect size is an important issue in the planning of clinical studies
of complementary and alternative medicine therapies. When a minimally important difference is not
available, researchers may estimate effect size using the published literature. This evidence-based
effect size estimation may be used to produce a range of empirically-informed effect size and
consequent sample size estimates. We provide an illustration of deriving plausible effect size ranges
for a study of acupuncture in the relief of post-chemotherapy fatigue in breast cancer patients.
Methods:  A PubMed search identified three uncontrolled studies reporting the effect of
acupuncture in relieving fatigue. A separate search identified five randomized controlled trials
(RCTs) with a wait-list control of breast cancer patients receiving standard care that reported data
on fatigue. We use these published data to produce best, average, and worst-case effect size
estimates and related sample size estimates for a trial of acupuncture in the relief of cancer-related
fatigue relative to a wait-list control receiving standard care.
Results: Use of evidence-based effect size estimation to calculate sample size requirements for a
study of acupuncture in relieving fatigue in breast cancer survivors relative to a wait-list control
receiving standard care suggests that an adequately-powered phase III randomized controlled trial
comprised of two arms would require at least 101 subjects (52 per arm) if a strong effect is assumed
for acupuncture and 235 (118 per arm) if a moderate effect is assumed.
Conclusion: Evidence-based effect size estimation helps justify assumptions in light of empirical
evidence and can lead to more realistic sample size calculations, an outcome that would be of great
benefit for the field of complementary and alternative medicine.
Background
In their content analysis of all scientific reviews of grant
applications submitted by the Community Clinical
Oncology Program for clinical trials of complementary
and alternative medicine (CAM) to the National Cancer
Institute, Buchanan and colleagues (p. 6685) indicated
that one of the five major concerns raised by reviewers has
been "justifying the anticipated effect sizes used to deter-
mine sample size."[1] With regards to published research
studies, meta-analytic and systematic reviews regularly
point to sample size as a troubling issue.[2] Often, the
treatment effects are positive and non-trivial in size, but
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results are non-significant due to insufficient sample size.
This recurrent finding suggests that when considering and
planning studies, CAM researchers may tend to over-esti-
mate expected treatment effect sizes.
Estimating effect size without data from a randomized
controlled trial (RCT) is an issue faced by researchers in
general. An approach that is often preferred is to power
the study to detect a minimally important difference
(MID)–the magnitude of improvement for which patients
would consider a course of treatment to be worthwhile.[3]
In some instances, an MID estimate may be unavailable so
a pilot study may be needed. When it is neither possible
to specify an MID nor feasible to collect pilot data,
researchers can make use of the published literature to
derive plausible effect size estimates.
We propose a four-step process of evidence-based effect size
estimation, especially for situations when there is evidence
from pre-post studies but little or no evidence from rand-
omized controlled trials. The first step is to draw upon
published literature to specify a range of assumptions
about (a) the amount of change in the treatment group
and (b) the amount of change in the control group. The
second step is to make a plausible assumption about the
amount of change in the treatment group relative to con-
trol based upon evidence gathered in step one. The third
step is to carry out a power analysis to estimate sample
size. The fourth step is to refine assumptions about effect
size. We illustrate evidence-based effect sized estimation
for a newly developing area of interest, acupuncture in the
treatment of fatigue in patients who have completed pri-
mary treatment for cancer.
Methods
Suppose that we plan to carry out a clinical trial and that
individuals with breast cancer will be randomly assigned
to either treatment (acupuncture) or control. Assume fur-
ther that the primary outcome of interest is continuous
rather than categorical. The preferred model of analysis in
this situation is the analysis of co-variance (ANCOVA)
because it controls for baseline imbalance and increases
the statistical power to detect a difference.[4,5]
Step 1: Reviewing the literature
Part A. Estimating effect of acupuncture in relieving fatigue
We carried out a systematic literature search in PubMed to
identify studies of acupuncture for relief of fatigue in
breast cancer survivors. In our initial search wave, we used
key words "breast cancer" in combination with "acupunc-
ture" and "fatigue" and then "breast cancer" with "acu-
puncture". We further searched the reference lists of
identified articles and then also used Google Scholar to
search the web. From the approximately 125 studies we
examined, only one met our three search criteria: (1) man-
ual acupuncture, (2) fatigue as a measured outcome, and
(3) breast cancer survivors as the target population. This
published study was an uncontrolled, Phase II study that
involved provision of acupuncture to fatigued breast can-
cer survivors over the course of approximately 8 weeks.[6]
In a second search wave, we looked for studies examining
the effect of acupuncture in relieving fatigue in persons
without breast cancer. This search identified two addi-
tional studies (see Table 1).[7,8]
The three studies referenced in Table 1 all assessed change
in fatigue. Each study shows acupuncture to have a bene-
ficial effect in relieving fatigue and each use different
measurements and patient populations. The Vickers study
used the nine-item Brief Fatigue Inventory (BFI), for
which higher scores reflect greater fatigue. The Harris
study employed the Multidimensional Fatigue Inventory
(MFI), which is also constructed so that higher scores
reflect greater fatigue. In contrast, the Hays et al. study
used the SF-36. In the SF 36, lower scores reflect greater
fatigue; for the sake of consistency with the BFI and the
MFI, we reverse the SF 36 scoring. One very important dif-
ference between the three studies is that they were carried
out with different patient populations: breast cancer sur-
vivors (Vickers), patients with fibromyalgia (Harris), and
consecutive patients from a clinic (Hays et al.). It may be
the case that acupuncture is more or less effective in reliev-
ing fatigue in these different populations.
To compare the effect of acupuncture in relieving fatigue,
we used G*Power 3 software[9,10] to calculate, on a study
by study basis, Cohen's D:
where mean1 and mean2 are the means at pre and post
measurements. The S.D. (standard deviation) is weighted
to take account of the standard deviation for the first and
the second mean and the third term with the correlation
(ρ) is present because we assume that these two standard
deviations are nonindependent:
Standard deviations may vary from pre to post; by
accounting for both, the resulting assumption is more
robust. For the power analysis, we used the following
specifications: a Type I error rate of α = .05, statistical
power of .80, a two-tailed test, and a rather conservative
correlation between pre and post measurements of 0.5. It
could be argued that a correlation of 0.7 is a more conven-
tional default value and if this were used, the resulting
Cohen's D would be higher (indicating a stronger effect
size). Since we are looking at the change from baseline to
Cohen’s D =
− mean mean
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follow-up within the same participants, the analytical
model we specify is a t-test for dependent means. The
standards given by Cohen to interpret D is that a large
effect size is one that is equal to or greater than 0.80, a
medium effect is one that is equal to or greater than 0.50
but less than 0.80, and a small effect is one that is equal to
or greater than 0.20 but less than 0.50.
Whereas the Vickers study yielded a large effect size, the
other two yielded small to medium effects. It is not sur-
prising that the Hays and Harris studies have a lower
Cohen's D than that reported in the Vickers study. The
Vickers study was designed specifically to study the effects
of acupuncture upon fatigue; they did so by only includ-
ing patients with greater than mild fatigue. In contrast, the
Harris and Hays studies did not specify exclusion or inclu-
sion criteria related to fatigue. Since patients in these stud-
ies will include people with low levels of fatigue that have
little room for improvement, the overall mean improve-
ment is lower.
Although the effect of acupuncture upon cancer-related
fatigue was large in the Vickers study, Price and col-
leagues[11] argued that if patients were to experience acu-
puncture according to the philosophy of Chinese
medicine (individualized treatment) they would achieve a
more complete relief of fatigue than those who experience
acupuncture according to the fixed-point standard pre-
scription used in that study. The three uncontrolled stud-
ies were performed on different populations, they used
different treatment protocols and, presumably, practition-
ers with different levels of skill and/or experience per-
formed them. The weighted average approach assumes,
essentially, that these differences have minimal effects
upon the clinical results. If there were reason to treat one
study as more predictive for the planned trial, a more
complicated weighting scheme could be developed. Simi-
larly, more emphasis could be placed on that trial, such as
we have done in developing alternative estimates for the
Vickers trial, namely VickersSMLG and Vickers90% (see
below).
Table 1: Information extracted from utilized studies concerning recovery from fatigue
Acupuncture Studies (Treatment)
Study ID Patient Population Instruments, Units n1
base 
2 Sbase 
3
f-up 
4
f-up 
5 Cohen's D
Vickers et al. Breast cancer survivors Brief Fatigue Inventory 31 6.47 1.21 4.55 2.16 1.02
VickersSMLG 31 6.47 1.21 4.97 2.16 0.80
Vickers90% 31 6.47 1.21 5.21 2.16 0.62
A-W.AVG 199 0.56
Hays et al. Consecutive patients SF-36 vitality/energy (reversed) 54 57.00 9.60 52.00 8.90 0.54
Harris et al. Patients with fibromyalgia Multi-dimen'l fatigue inventory 114 16.60 3.19 14.98 3.89 0.45
Wait-list Control Groups
Carpenter Breast cancer survivors Fatigue Scale from FACT 16 5.82 5.00 3.99 5.00 0.37
Courneya Breast cancer survivors Multidimensional Fatigue Inventory 28 10.80 8.80 8.80 8.10 0.24
Stanton Breast cancer survivors Linear analogue scale for fatigue 136 44.00 19.90 40.16 18.40 0.20
C-W.AVG 246 0.16
Pinto Breast cancer survivors POMS S. Form Fatigue Subscale 43 41.66 25.04 42.28 26.20 0.02
Badger Breast cancer survivors SF 36 (reversed) 24 37.63 25.50 37.15 28.20 -0.02
1. number of observations.
2. mean at baseline.
3. standard deviation at baseline.
4. mean at follow-up.
5. standard deviation at follow-up.
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In our subsequent sections, we consider the effect of acu-
puncture in relieving cancer-related fatigue from a variety
of perspectives. First, we consider whether the effect
reported by Vickers (Cohen's D = 1.02) is representative of
what would generally occur in a population of breast can-
cer survivors. In another approach we combine the infor-
mation from the three studies via a weighted average,
which yields a Cohen's D of 0.56. In a third approach, we
adjust the follow-up mean reported by Vickers down-
wards so that the Cohen's D is capped at the smallest
value in the large effect size range specified by Cohen (i.e.,
0.80, which yields a follow-up mean of 4.97). A fourth
approach is to argue that the Vickers study captured a true
effect but that the scores at follow-up may have been unu-
sually large. That is to say, we consider the mean reported
by Vickers at follow-up within the context of a 90% confi-
dence interval and take the lower bound (a follow-up
mean of 5.21). We refer to these approaches, respectively
as: Vickers, A-W.AVG, VickersSMLG, and Vickers90%. The
Cohen's D for each is reported in Table 1.
Part B. Estimating effect of participating in a wait-list control group 
receiving usual care
Birch, in a review of placebo effects in acupuncture
research, advocates for a distinction between trials that
involve an inert placebo (such as wait list controls) and
those that involve non-inert treatments such as sham acu-
puncture.[12] Though they do not use the terminology of
inert placebos, Walach and Jonas point out that such
groups account for the beneficial effect of participation in
a clinical trial that is due to natural history, spontaneous
remission, and regression to the mean.[13] The use of
non-inert placebos, such as sham acupuncture, are known
to produce an effect that is stronger than that of an inert
placebo.[12] There are several hypotheses regarding why
but as of yet none are strongly supported by the data and
agreed upon by a wide number of experts. This is not a
concern for the issue at hand because we use the pub-
lished literature to estimate an effect for an inert placebo
by identifying wait-list controls receiving standard care.
To identify studies that investigated the effect of an inert
placebo in relieving fatigue in breast cancer patients, we
again carried out a systematic search of PubMed, this time
using "breast cancer" and "fatigue" with the following
limits: English and Randomized Controlled Trial. Again,
the search yielded approximately 200 hits, of which we
identified five[14-18] (see Table 1) that met our criteria:
(1) a randomized controlled trial with fatigue as a meas-
ured outcome, (2) a wait-list control group receiving usual
care, and (3) target breast cancer survivors. In addition, we
hand-searched reference lists of identified articles, identi-
fied systematic reviews of similar topics, and then also
used Google Scholar to search the web.
At first glance, it might appear inappropriate to use non-
acupuncture trials from fatigue studies to extrapolate
power-relevant information. The key point is that these
control arms are wait-list controls. The logic of using this
information is that there will be no appreciable systematic
difference in the amount of change experienced by wait-
list control groups in an acupuncture trial and that experi-
enced by wait-list control groups in, for example, exercise
trials.
We calculated a Cohen's D for each trial. Notice that in
four out of the five trials, breast cancer patients who
received an inert placebo, as a group, showed a recovery in
fatigue. To summarize the information from the five wait-
list control groups receiving standard care, we carried out
a weighted average (C-W.AVG), with the resultant pooled
Cohen's D estimated to be 0.16.
Step 2: Estimating an Inclusive effect size
Using the published literature to estimate the effect of acu-
puncture upon relieving fatigue relative to a wait-list con-
trol receiving standard care is based upon the assumption
that the patient population employed by Vickers is com-
parable to those in the controlled studies because they all
include breast cancer survivors. However, the Vickers
study had in place inclusion/exclusion criteria that
bounded this population to a subset of people with mod-
erate or high fatigue, while the controlled studies did not
have in place these criteria. The potential problem is that
moderate and highly fatigued breast cancer survivors may
experience regression to the mean at a higher rate than
those who are only mildly fatigued. While this explana-
tion cannot be ruled out, it is the case that epidemiologi-
cal and related studies make the point that fatigue is one
of the most persistent  problems facing cancer survi-
vors.[19,20] Without any evidential basis to assume that
breast cancer survivors with moderate and high amounts
of fatigue would be more likely than others to progress
towards recovery quickly, we assume that the effects for
the general population of breast cancer survivors as cap-
tured in the five studies above are also representative of
the subset of breast cancer survivors with moderate and
high levels of fatigue.
In Table 2, we display a series of comparisons between
treatment and control. We chose these comparisons to
provide a sense of the range of potential effect sizes, as
well as to offer some insight into the consequences of par-
ticular assumptions that underlay the calculation of effect
size. We compute an effect size for the comparison
between Vickers and Badger. The effect size for the Badger
study and the result is slightly negative because, on aver-
age, participants in the control group reported more
fatigue at study conclusion than at study beginning. Since
the floor for Cohen's D is zero, we set Cohen's D = 0 forBMC Complementary and Alternative Medicine 2009, 9:1 http://www.biomedcentral.com/1472-6882/9/1
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the Badger study. Comparing Vickers and Badger yields
the largest effect size. Of all the effect size calculations for
treatment that involve the Vickers study, the weighted
average has the lowest effect. Of all the effect size calcula-
tions for control, the one reported by Carpenter is the larg-
est and we see this as representing an upper bound for the
amount of improvement a control group could show in
the context of an RCT. To produce a conservative estimate
of Cohen's D between treatment and control, we therefore
compare the weighted average for acupuncture to Carpen-
ter's control group. To further our sense of the way that
stochastic processes may influence the realized effect size,
we compare Vickers90 to first Carpenter and then the
weighted average of control group studies.
A final method we employ is to compare the two weighted
averages. This method relates very closely to a random
effects meta-analysis[21] which treats each study as a unit.
Figure 1 displays a forest plot of the meta-analysis, with
the 5 wait-list controlled studies in the upper half of the
plot and the three acupuncture studies in the lower half of
the plot. The overall effect for the controls (0.16) is equal
to the weighted average of the controls. Similarly, the
overall effect for the acupuncture studies (0.57) is equal to
the weighted average for the acupuncture studies (within
rounding error). Is the effect of acupuncture in relieving
fatigue attributable to chance or is there a treatment effect?
One of the strengths of the random effects meta-analysis
is that each study can be defined by a covariate such as
average duration of follow-up, a measure of study quality,
or a measure of geographic location of study and a formal
statistical test can be carried out on that covariate. For our
example, the covariate of interest is whether participants
in the study received acupuncture or standard care. The p-
value (0.003) indicates that subjects who participated in a
study that involved administration of acupuncture experi-
enced a significantly higher amount of fatigue relief than
those subjects who participated in a study as a member of
a control group receiving standard care.
The values of Cohen D displayed in Table 2 illustrate that
the effect of acupuncture in relieving fatigue among breast
cancer survivors relative to a wait-list control receiving
standard care varies from very large (1.02) to very small
(0.11). If it is assumed that acupuncture produces an
extremely large effect, as reported by Vickers, and that
patients in the wait-list control will not improve (Badger),
one would conclude that acupuncture has a large effect
upon relieving cancer-related fatigue (Cohen's D = 1.02).
If it is assumed that people in the control group will
recover at a rate equal to the average of the controls (A-
W.AVG) and that the effect for acupuncture is the smallest
large effect (VickersSMLG), one would conclude that the
difference between the groups is moderate (hovering
around 0.50). If we continue to assume that the effect of
acupuncture is at the level of the smallest large effect, but
that the control group will evidence a relatively great deal
of recovery, as was the case in the Carpenter study, then
one would conclude that acupuncture produces a some-
what small effect in relieving cancer-related fatigue in
breast cancer survivors (Cohen's D of approximately
0.20).
Results
Step 3: Power Analysis
To carry out a power analysis for an ANCOVA with
G*Power 3, we begin with a baseline model that does not
include a coefficient for the treatment effect:
yi = β0 + β1X1 + ei.( 3 )
In model (3), yi is the amount of fatigue each participant
reports at completion of the treatment. The coefficient β0
is a constant, representing the mean amount of fatigue in
the control group at completion, given a score of zero
Table 2: Effect and sample size calculations
Treatment 
Group
Control Group Treatment Effect 
Size
Control Effect 
Size
Comparison 
Effect Size
R2 Effect Size f2 Sample Size
Vickers Badger 1.02 0.00 1.02 0.21 0.27 40
VickersSMLG C-W.AVG 0.80 0.16 0.64 0.09 0.10 101
Vickers90% C-W.AVG 0.62 0.16 0.46 0.05 0.05 187
A-W.AVG C-W.AVG 0.56 0.16 0.40 0.04 0.04 235
Vickers90% Carpenter 0.62 0.37 0.25 0.02 0.02 476
A-W.AVG Carpenter 0.56 0.37 0.19 0.01 0.01 957BMC Complementary and Alternative Medicine 2009, 9:1 http://www.biomedcentral.com/1472-6882/9/1
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fatigue at baseline. The coefficient β1 represents the scaled
contribution of fatigue at baseline on fatigue at comple-
tion. The parameter eij represents the difference between
an individual's predicted change in fatigue and actual
change in fatigue.
To specify the power analysis, we assume a Type I error
rate of α = .05 and statistical power of .80. There are two
predictors in the original model, so there are 2 degrees of
freedom in the numerator and we add one predictor so
that number of predictors is specified as 1. We also need
to specify how much the R2 will increase when this one
predictor for treatment effect is included into the model.
This requires a transformation from Cohen's D to R2, for
which we use a freely available effect size calculator.[22]
Information for the power calculation is found in the R2
column of Table 2.
We power this equation with respect to an R2 that is statis-
tically different from a model with β0 and β1. In doing so,
we assume that one additional parameter will be added to
the model, β2, which is associated with the independent
variable of interest: treatment effect. The coefficient β2 rep-
resents the mean amount of fatigue at completion
amongst people who received acupuncture (the treat-
ment), holding constant fatigue at baseline (β1).
The final column of Table 2 shows that the sample size
needed for the ANCOVA model described above (1) in
light of assumptions about effect size is very large, ranging
from 40 (20 per arm) to 957 (479 per arm). If a very nar-
row range resulted from step 3, this would be a potential
stopping point. In most cases, however, we would expect
that researchers would benefit from moving on to step 4.
Step 4: Refine Assumptions
The smallest sample size (n = 40; 20 per arm) is required
when it is assumed that acupuncture produces an extraor-
dinary result and that the control group does not recover
at all, as was the case in the Badger study. When it is
Meta-analytic results of fatigue recovery Figure 1
Meta-analytic results of fatigue recovery. Acupuncture vs. breast cancer survivor wait list controls.BMC Complementary and Alternative Medicine 2009, 9:1 http://www.biomedcentral.com/1472-6882/9/1
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assumed that acupuncture produces the smallest large
effect and that the control group recovers at a rate equal to
the average across all control studies, than the sample size
requirements are larger (n = 101; 52 per arm), but very
feasible. If we assume that acupuncture has a moderate
effect, as is associated with Vickers90%, and that the con-
trol group recovers at a rate equal to the average across all
control studies, then the sample size requirements double
to n = 187 (94 per arm). If we continue to assume that the
control group recovers at an average rate but that the effect
of acupuncture is only moderate (average from all stud-
ies), the sample size requirements are yet higher (n = 235;
118 per arm).
It seems unrealistic to assume that on average participants
in the control group will not recover at all (Badger) or
even that there will be minimal recovery (Pinto).
Although it is conceivable that an acupuncture arm will
produce results just as strong as those in the Vickers study,
it is also plausible that it might be a little less. At this
point, the research team would take stock of their
resources and goals in light of the assumptions they con-
sider to be most reasonable. If they want to proceed with
a phase III type trial, it would seem that at least 101 sub-
jects (52 per arm) would be required. Is this feasible? If
they decide to pursue a trial along the lines of a phase IIB
type, then they would want to adjust their expectations in
terms of results.
Epilogue
Molassiotis and colleagues[23] recently published a pilot
randomized controlled trial that provides a valuable
opportunity to compare the effect sizes we estimated from
uncontrolled data to randomized controlled trial data.
Their study involves 47 patients randomizes to either an
acupuncture group (n = 15), an acupressure group (n =
16) or a sham acupuncture group (n = 16). The 20-minute
acupuncture session consisted of inserting needles into
three points associated with energy (LI4, SP6, and ST36)
bilaterally three times a week over the course of 2 weeks.
The sham acupressure group was taught to apply pressure
to three points not associated with energy (LI12, GB33
and BL61). Researchers collected information about
fatigue with the Multidimensional Fatigue Inventory
(MFI) at baseline, end of the 2-week treatment, and fol-
low-up (2 weeks after completing treatments). We extract
relevant information from this study and compute
Cohen's D effect size (see Table 3).
Results from the Molassiotis study suggest a large effect for
the acupuncture group and has ambiguous implications
for the control group. At the conclusion of the two week
treatment, patients in the Molassiotis acupuncture group
reported a tremendous improvement in fatigue (Cohen's
D of 2.15) and at the end of the follow-up period reported
a large improvement in fatigue relative to baseline
(Cohen's D of 1.25). The amount of recovery exhibited by
the Molassiotis control group essentially spans the full
range presented in the wait-list control groups (Table 1),
with a Cohen's D of 0.04 at the conclusion of the two
week treatment and a Cohen's D of 0.32 at the end of the
follow-up period.
Table 3: Information extracted from randomized controlled pilot study involving acupuncture for fatigue
Acupuncture Studies (Treatment)
Study ID Patient Population Instruments, Units n (1)
base (2) Sbase (3)
f-up(4) Sf-up (5) Cohen's D
Moulassiotis, Baseline to 
Completion
Cancer survivors, primarily 
lymphoma and breast
Multidimensional 
Fatigue Inventory
13 16.4 2.40 10.5 3.00 2.15
Moulassiotis, Baseline to 
Follow-up
Cancer survivors, primarily 
lymphoma and breast
Multidimensional 
Fatigue Inventory
13 16.4 2.40 12.8 3.20 1.25
Wait-list Control Groups
Moulassiotis, Baseline to 
Completion
Cancer survivors, primarily 
lymphoma and breast
Multidimensional 
Fatigue Inventory
13 17.8 2.50 17.7 2.60 0.04
Moulassiotis, Baseline to 
Follow-up
Cancer survivors, primarily 
lymphoma and breast
Multidimensional 
Fatigue Inventory
13 17.8 2.50 16.9 3.00 0.32
6. number of observations.
7. mean at baseline.
8. standard deviation at baseline.
9. mean at follow-up.
10. standard deviation at follow-up.
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The Molassiotis results, given that they come from a rand-
omized controlled trial, merit primary consideration in
estimating an effect size. But there is substantial variability
in means (and standard deviations) across the three time
periods. In situations with such variability, information
from the observational studies may be used to finalize
assumptions. In the instance of acupuncture for fatigue,
one conservative approach would be to use the effect size
reported from the follow-up for treatment (Cohen's D of
1.25) and the effect size from the follow-up for the control
(Cohen's D of 0.32), which yields a comparison effect size
of 1.25 – 0.32 = 0.93.
Discussion
Specifying anticipated effect size of treatment relative to
control requires assumptions. To justify these assump-
tions, we propose evidence-based effect size estimation:
anchoring assumptions in the published literature as
much as possible, preferably to results from randomized
controlled trials. It may be that at least some researchers
have employed a similar process in grant applications and
would therefore see nothing novel about evidence-based
effect size estimation. Nonetheless, it is important to
make this process explicit. One reason to do so is because
effect sizes derived from published literature may exhibit
a considerable amount of variation. In such situations,
researchers will need to discern the key factors that pro-
duce variability across the studies. Some examples that
involve patients include differences in the length of ill-
ness, severity of illness, and comorbidities. Clinic-based
examples include differences in clinician experience and
skill, treatment length, and treatment regiment. We are
hopeful that a formal conversation about these processes
will produce a consensus about the best possible standard
approach.
The studies we employed to estimate the effect size of the
control group reinforce the lesson that when there are a
small number of participants, results may be unstable.
The Badger study, with 24 participants, shows there to be
no improvement in fatigue in the control group, but the
Carpenter study, with 16 participants, shows there to be
considerable improvement. When the control group is
comprised of only a small number of participants,
improvement by just a few people may effectuate a notice-
able improvement for the control group as a whole.
Importantly, improvement may be due to control group
participants taking advantage of the therapy from other
sources ("drop-ins")[24]25 or more simply to their own
natural healing systems becoming activated in response to
participating in a clinical trial (the Hawthorne effect). This
uncertainty points to the need for keeping track of drop-
ins, both for the sake of clarifying which process may be
operating to effectuate recovery in the control group as
well as for purposes of statistical analyses. Disentangling
these effects may provide useful clues as to the potential
usefulness of acupuncture for those carrying out meta-
analyses summarizing studies with mixed results.
Conclusion
Evidence-based effect size estimation leads to elaborating
assumptions in light of empirical evidence and showing
the extent to which assumptions are robust. Our illustra-
tion with acupuncture for cancer-related fatigue shows
that several different assumptions are plausible. For this
reason, assumptions may be more open to discussion. We
see this as positive because discussion would likely lead to
more realistic sample size calculations – an outcome that
would be of great benefit for the field of complementary
and alternative medicine.
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